Skip to content

Health— page 39

health

A day in the life of Congo’s overstretched Ebola surveillance teams

By Clement Bonnerot BUNIA, Democratic Republic of Congo, July 28 (Reuters) – On a good day, there are only four cars available to ferry surveillance teams round the city of Bunia, the epicentre of an Ebola outbreak surging through the Democratic Republic of Congo. They were all out when Dr Moubarack

· SRN Health
A day in the life of Congo’s overstretched Ebola surveillance teams
health

Federal survey shows promising trends for youth mental health and drug use

A key U.S. government report on mental health, substance use and addiction showed continued improvements in several metrics, especially among young people. There was some uncertainty about the future of the National Survey on Drug Use and Health last year, when the entire 17-member team responsible

· SRN Health
Federal survey shows promising trends for youth mental health and drug use
health

Boston Scientific unveils new restructuring plan, expects job cuts

July 27 (Reuters) – Boston Scientific’s board has approved a new company-wide restructuring plan aimed at cutting costs and to better position the company for future growth, the medical device maker said in a regulatory filing on Monday. Here are some details: • The company said the plan, approved o

· SRN Health
Boston Scientific unveils new restructuring plan, expects job cuts
health

Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty

July 27 (Reuters) – Hospital operator Universal Health Services lowered its full-year profit forecast on Monday, citing changes in reimbursements related to certain Medicaid supplemental payment programs, sending its shares down nearly 8% in extended trading. Medicaid supplemental payment programs p

· SRN Health
health

World risks HIV resurgence as funding falls 18%, UNAIDS says

By Emma Farge GENEVA, July 27 (Reuters) – The world risks a resurgence of the HIV epidemic after global funding fell by nearly a fifth last year, the U.N. body fighting AIDS said on Monday. Washington previously accounted for 75% of international HIV funding before President Donald Trump’s return to

· SRN Health
World risks HIV resurgence as funding falls 18%, UNAIDS says
health

Michigan reports 9,253 cyclosporiasis cases in ongoing outbreak

July 27 (Reuters) – Michigan health officials reported 9,253 cases in an outbreak of cyclosporiasis on Monday, an increase of 1,077 cases since its last update on Friday. The outbreak of the intestinal infection in Michigan has resulted in 160 hospitalizations, according to the state health departme

· SRN Health
health

Philip Morris doubles Colorado campus investment to $1.2 billion

July 27 (Reuters) – Philip Morris International said on Monday it had doubled its planned investment in its Colorado manufacturing campus to about $1.2 billion through 2028, as it expands production capacity for the Zyn nicotine pouch business. The company in 2024 had initially announced a $600 mill

· SRN Health
Philip Morris doubles Colorado campus investment to $1.2 billion
health

Sarepta names former Abbvie president as CEO as Ingram retires

July 27 (Reuters) – Sarepta Therapeutics said on Monday it appointed former Tessera Therapeutics CEO Michael Severino its chief executive, effective July 28. The longtime AbbVie executive, will succeed Doug Ingram. Shares of the company were up nearly 6% in premarket trading. • The appointment of Se

· SRN Health
Sarepta names former Abbvie president as CEO as Ingram retires
health

FDA approves Freenome’s blood test for colorectal cancer screening

By Sahil Pandey July 27 (Reuters) – The U.S. FDA has approved Freenome’s blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott to launch it in the U.S. this fall, the companies said on Monday. Shares of Freenome were up about 4% in morning trading. Here are

· SRN Health
FDA approves Freenome’s blood test for colorectal cancer screening
health

AstraZeneca drug prices evolving in response to Trump policy, executive says

July 27 (Reuters) – AstraZeneca has been adjusting its pricing strategy for new drug launches in response to U.S. President Donald Trump’s “most-favoured-nation” policy seeking lower drug prices for Americans, a senior company executive said on Monday. “Our pricing approach across all of launches no

· SRN Health
AstraZeneca drug prices evolving in response to Trump policy, executive says
health

MapLight’s schizophrenia drug fails once-daily test, shares plunge

July 27 (Reuters) – MapLight Therapeutics said on Monday its schizophrenia drug failed to show statistically significant symptom improvement in the once-daily dosing arm of a mid-stage trial, sending its shares tumbling 55% in premarket trading. Here are the details: • The company was testing ML-007

· SRN Health
health

FDA staff flags data concerns about Capricor’s therapy; shares plunge

By Christy Santhosh and Sahil Pandey July 27 (Reuters) – U.S. FDA staff reviewers raised concerns about the effectiveness data for Capricor Therapeutics’ cell therapy for a heart condition related to Duchenne muscular dystrophy, dragging the company’s shares 65% lower in early trading. The briefing

· SRN Health
FDA staff flags data concerns about Capricor’s therapy; shares plunge
health

Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO

July 27 (Reuters) – Late-stage drug developer Apnimed is targeting a valuation of up to $608 million in its initial public offering in the United States. The sleep apnea pill developer is seeking to raise up to $160 million by offering 10 million shares priced between $14 and $16 apiece, a regulator

· SRN Health
health

Goldman Sachs Alternatives buys control of Italian medtech firm Numantec

MILAN, July 27 (Reuters) – The private equity arm of Goldman Sachs has agreed to acquire control of Italian medical equipment maker Numantec from White Bridge Investment, the companies said, betting on a business with steady revenues amid macroeconomic uncertainty. Based near the northern Italian ci

· SRN Health
Goldman Sachs Alternatives buys control of Italian medtech firm Numantec
health

India firm on ‘energy drink’ crackdown despite Pepsi, Red Bull, Monster protest

By Aditya Kalra NEW DELHI, July 27 (Reuters) – India has ordered makers of high-caffeine beverages sold as “energy drinks” to stop using that description, rejecting efforts to stall the regulatory intervention in a fast-growing market expected to be worth $1.6 billion by 2028, according to documents

· SRN Health
India firm on ‘energy drink’ crackdown despite Pepsi, Red Bull, Monster protest
health

AstraZeneca’s rare disease drug misses main goal in late-stage trial

July 27 (Reuters) – AstraZeneca said on Monday its rare disease drug Ultomiris failed a late-stage trial in patients with a blood vessel complication following a stem cell transplant, the latest in a series of setbacks this year that have fuelled concerns about the drugmaker’s pipeline. Here are som

· SRN Health
AstraZeneca’s rare disease drug misses main goal in late-stage trial
health

AstraZeneca profit beat, bullish tone ease worries over drug pipeline

By Pushkala Aripaka and Maggie Fick July 27 (Reuters) – AstraZeneca stood by its annual and long-term forecasts on Monday, expressing confidence that recent trial setbacks had not undermined its long-term prospects as second-quarter profit beat market expectations. Strong demand for cancer and rare

· SRN Health
AstraZeneca profit beat, bullish tone ease worries over drug pipeline
health

Trial begins for Lindsay Clancy, mother on trial in deaths of her 3 children

PLYMOUTH, Mass. (AP) — In the months after the birth of her third child, Lindsay Clancy ‘s mental health collapsed. Manic, unable to sleep and stricken with thoughts of harming herself, she sought care from experts in postpregnancy mood disorders, was put on multiple psychiatric medications, and whe

· SRN Health
Trial begins for Lindsay Clancy, mother on trial in deaths of her 3 children
health

Argenx to buy Forte Biosciences for about $2.2 billion

July 27 (Reuters) – Belgian-Dutch immunology company argenx will buy Forte Biosciences to add experimental autoimmune drug FB102 to its portfolio, the company said on Monday. Argenx will pay $77 a share in cash, valuing the U.S. drug developer at about $2.2 billion, in a deal that gives it a first-i

· SRN Health
health

Congo says number of confirmed Ebola cases surpasses 3,000

July 25 (Reuters) – The number of confirmed Ebola cases in the Democratic Republic of Congo has increased to 3,075, including 1,354 deaths, government data showed on Saturday. (Reporting by Rajveer Singh Pardesi in Bengaluru; Editing by David Gregorio) Brought to you by www.srnnews.com

· SRN Health
Congo says number of confirmed Ebola cases surpasses 3,000
health

Jetting off for a summer vacation? How to eat and drink to minimize jet lag

Jet lag threatens to turn even a dream vacation into a slog. And with peak travel season underway, millions of people may have to contend with this disorienting condition, which can cause sleep disturbances, daytime tiredness, headaches and nasty gastrointestinal symptoms. But you can minimize the e

· SRN Health
Jetting off for a summer vacation? How to eat and drink to minimize jet lag
health

Michigan battles massive outbreak as state reels from Trump cuts

By Julie Steenhuysen and Tom Polansek CHICAGO, July 25 (Reuters) – Two weeks before the U.S. Centers for Disease Control and Prevention issued its cyclosporiasis health warning on July 14, Michigan warned of an unusually large outbreak of parasitic disease that was causing explosive diarrhea. New ca

· SRN Health
Michigan battles massive outbreak as state reels from Trump cuts